Bristol Myers Squibb (BMY) Profit After Tax (2009 - 2026)
Bristol Myers Squibb's Profit After Tax came in at $3.32 billion for Q2 2026, up 152.6% from $1.31 billion a year earlier and up 23.8% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Profit After Tax (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Bristol Myers Squibb reported Profit After Tax of $9.28 billion, up 83.1% year-over-year; for FY2025, it came in at $7.06 billion.
- Going back by year, Profit After Tax was -$8.93 billion in FY2024, $8.04 billion in FY2023 (+26.7%), $6.35 billion in FY2022 (-9.5%) and $7.01 billion in FY2021.
- The Q2 2026 figure represents the highest quarterly Profit After Tax in data going back to Q1 2009.
- Year-over-year, Profit After Tax increased in three of the last six quarters, with growth averaging 14.5%.
- The fastest year-over-year change in Profit After Tax over five years came in Q2 2026 (growth of 152.6%), and the weakest in Q4 2024 (a decline of 95.7%).
- Business Quant data shows BMY's Profit After Tax at $2.68 billion (Q1 2026), $1.09 billion (Q4 2025) and $2.2 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Bristol Myers Squibb | 120.21 Bn | 71.48 Bn | 9.25 Bn | 3.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.32 Bn |
| Mar 31, 2026 | 2.68 Bn |
| Dec 31, 2025 | 1.09 Bn |
| Sep 30, 2025 | 2.20 Bn |
| Jun 30, 2025 | 1.31 Bn |
| Mar 31, 2025 | 2.46 Bn |
| Dec 31, 2024 | 76.00 Mn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | -11.91 Bn |
| Dec 31, 2023 | 1.76 Bn |
| Sep 30, 2023 | 1.93 Bn |
| Jun 30, 2023 | 2.08 Bn |
| Mar 31, 2023 | 2.27 Bn |
| Dec 31, 2022 | 2.03 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.43 Bn |
| Mar 31, 2022 | 1.28 Bn |
| Dec 31, 2021 | 2.37 Bn |
| Sep 30, 2021 | 1.55 Bn |
API Access
Bristol Myers Squibb Profit After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();